A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Recruiting now · Phase 4
Conditions studied: Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
In brief
The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) who have completed study IM011074 or Study IM011132
Key facts
- Study ID
- NCT06875960
- Run by
- Bristol-Myers Squibb
- People needed
- 35
- Starts
- 2026-02-24
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-03-30
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must have completed Study IM011074 or Study IM011132 through the protocol-required treatment period.
- Participants must be, based on the physician's medical judgement, likely to receive benefit from receiving treatment with deucravacitinib.
- Participants must have received IP within 60 days of enrollment. Exceptions may be granted based upon consultation with BMS.
You may not qualify if…
- Participants must not have any disease or medical condition that, in the opinion of the physician, would make the subject unsuitable for this protocol, would interfere with the interpretation of subject safety or considered unsuitable by the physician for any other reason.
- Participants must not have any evidence of active Tuberculosis (TB).
- Other protocol-defined Inclusion/Exclusion criteria apply.
Where it is running
- New York University School Of Medicine — New York, New York, United States (enrolling)
- Oklahoma Medical Research Foundation — Oklahoma City, Oklahoma, United States (enrolling)
- Local Institution - 0001 — Farmington, Connecticut, United States
- Local Institution - 0003 — Jackson, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.